Envoy Medical holder Alta Partners owns 2.59%

Envoy Medical, Inc. (COCH) reports in this Schedule 13G/A Amendment No. 1 that Alta Partners LLC beneficially owns 2,054,011 shares of Class A common stock, all issuable upon exercise of warrants.

Rhea-AI Filing Summary

Envoy Medical, Inc. (COCH) reports in this Schedule 13G/A Amendment No. 1 that Alta Partners LLC beneficially owns 2,054,011 shares of Class A common stock, all issuable upon exercise of warrants. This position represents 2.59% of the Class A common stock, with sole voting and dispositive power over all such shares.

Alta Partners LLC reports no shared voting or dispositive power and confirms that its ownership is 5 percent or less of the class. The filing is signed by Steven Cohen as Managing Member on September 14, 2026.

Key Figures

Beneficial ownership shares: 2,054,011 shares Percent of class owned: 2.59% Sole voting power: 2,054,011 shares +2 more

5 metrics

Beneficial ownership shares 2,054,011 shares Class A common stock issuable upon exercise of warrants, reported by Alta Partners LLC

Percent of class owned 2.59% Percentage of Envoy Medical, Inc. Class A common stock beneficially owned by Alta Partners LLC

Sole voting power 2,054,011 shares Shares over which Alta Partners LLC has sole power to vote or direct the vote

Shared voting power 0 shares Shares over which Alta Partners LLC has shared power to vote

Sole dispositive power 2,054,011 shares Shares over which Alta Partners LLC has sole power to dispose or direct disposition

Key Terms

beneficially owned, Sole Voting Power, dispositive power, warrants, +1 more

5 terms

beneficially owned financial

"Amount beneficially owned: 2,054,011 shares of Class A common stock"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power financial

"Sole Voting Power 2,054,011.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

dispositive power financial

"Sole Dispositive Power 2,054,011.00"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

warrants financial

"representing shares issuable upon exercise of warrants"

Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

Class A Common Stock financial

"Title of class of securities: Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What ownership stake in COCH does Alta Partners LLC report in this Schedule 13G/A?

Alta Partners LLC reports beneficial ownership of 2,054,011 shares of Envoy Medical, Inc. (COCH) Class A common stock, representing 2.59% of the class, with sole voting and dispositive power over all such shares.

Are Alta Partners LLC’s reported COCH shares currently outstanding or tied to warrants?

The 2,054,011 shares reported by Alta Partners LLC are shares issuable upon exercise of warrants for Envoy Medical, Inc. Class A common stock, rather than currently outstanding common shares owned outright.

Does Alta Partners LLC exceed 5% ownership of Envoy Medical, Inc. (COCH)?

No. Alta Partners LLC reports beneficial ownership of 2.59% of Envoy Medical, Inc. Class A common stock and indicates ownership of 5 percent or less of the class in the filing.

What voting and dispositive powers over COCH shares does Alta Partners LLC report?

Alta Partners LLC reports sole power to vote and dispose of 2,054,011 Envoy Medical, Inc. Class A shares (issuable upon exercise of warrants) and zero shared voting or shared dispositive power.

Who signed the Schedule 13G/A for Envoy Medical, Inc. and in what capacity?

The filing is signed by Steven Cohen as Managing Member of Alta Partners LLC, dated September 14, 2026, certifying the reported beneficial ownership in Envoy Medical, Inc. Class A common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 04:26 PM Accepted by SEC EDGAR 09/14/2026 - 04:25 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Envoy Medical, Inc.

(Name of Issuer)

Class A Common Stock

(Title of Class of Securities)

29415V117

(CUSIP Number)

08/10/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 29415V117

1

Names of Reporting Persons

Alta Partners LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

NEW YORK

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,054,011.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,054,011.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,054,011.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

2.6 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Envoy Medical, Inc.
(b)	Address of issuer's principal executive offices: 4875 WHITE BEAR PARKWAY, 4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE, MINNESOTA, 55110.
Item 2.
(a)	Name of person filing: Alta Partners LLC
(b)	Address or principal business office or, if none, residence: 1205 Franklin Avenue Garden City, New York 11530
(c)	Citizenship: New York Limited Liability Company
(d)	Title of class of securities: Class A Common Stock
(e)	CUSIP No.: 29415V117
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 2,054,011 shares of Class A common stock, representing shares issuable upon exercise of warrants
(b)	Percent of class: 2.59%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 2,054,011 shares of Class A common stock
	(ii) Shared power to vote or to direct the vote: 0 shares of Class A common stock
	(iii) Sole power to dispose or to direct the disposition of: 2,054,011 shares of Class A common stock
	(iv) Shared power to dispose or to direct the disposition of: 0 shares of Class A common stock
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Alta Partners LLC

Signature:	/s/ Steven Cohen
Name/Title:	Steven Cohen, Managing Member
Date:	09/14/2026